Archive explorer

Browse & search snapshots

Important note

Browse and search historical snapshots. This is an archive — not current guidance or medical advice. Archived content may be incomplete, outdated, or superseded. For up-to-date recommendations, always consult the official source website.

For background on coverage and capture methods, see Methods & coverage.

Browse archived sites

Browse all sources →

Biodisponibilité et bioéquivalence - Canada.ca

Health CanadaCaptures 2Latest capture Apr 13, 2026fr

Biodisponibilité et bioéquivalence ICH M9 Dispense de démonstration de bioéquivalence fondée sur le système de classification biopharmaceutique Ligne directrice: Conduite et analyse des études de biodisponibilité comparatives [2018-06-08] Normes en matière d'études de…

Examen de la réglementation des essais cliniques : mesures ciblées pour un cadre renforcé (Version PDF - 102 Ko) Contact: Examen du cadre de réglementation des essais cliniques Direction générale des produits de santé et des aliments Santé Canada Mars 2008 Table des matières 1…

Annual Report on Fighting Against Forced Labour and Child Labour in Supply Chains For the Financial Reporting Period: April 1, 2024, to March 31, 2025 General Overview This annual report is prepared in accordance with the requirements of the Fighting Against Forced Labour and…

Reporting obligations under the Fighting Against Forced Labour and Child Labour in Supply Chains Act Report submitted by the Canadian Institutes of Health Research (CIHR) for Fiscal Year 23/24 On this page Part 1: Identifying Information Part 2: Report Contents 2.1 Structure,…

Annexe 7 aux lignes directrices sur les bonnes pratiques de fabrication - certaines drogues en vente libre (GUI-0066) : Aperçu Aperçu Orientation Définitions Références Télécharger le format de rechange (Format PDF, 735 ko, 26 pages) Organisation : Santé Canada Date publiée : 29…

Summary of Pharmaceutical Survey Findings on R&D Spending and Investments by Rx&D Members - 2010 Canada's Research-Based Pharmaceutical Companies (Rx&D) (the " Company" ) on behalf of the Steering Committee, made up of members from: Rx&D; Industry Canada; Patented Medicine Prices…

Canadian Institutes of Health Research – 2017 to 2018 Fees Report - CIHR

Canadian Institutes of Health ResearchCaptures 38Latest capture Apr 13, 2026en

Canadian Institutes of Health Research – 2017 to 2018 Fees Report At the Canadian Institutes of Health Research (CIHR), we know that research has the power to change lives. As Canada’s health research investment agency, we collaborate with partners and researchers to support the…

Page 2707 of 6399Showing 27061-27070 of 63986

Early release: coverage and features are still expanding.